Literature DB >> 31192122

An in vivo Like Micro-Carcinoma Model.

Sandra Camargo1, Yulia Shamis2, Assaf Assis1, Eduardo Mitrani1.   

Abstract

We here present a novel micro-system which allows to reconstitute an in vivo lung carcinoma where the various constituting epithelial and/or stromal structural and/or cellular components can be incorporated at will. In contrast to various "organs on a chip" the model is based on the observation that in nature, epithelial cells are always supported by a connective tissue or stroma. The model is based on acellular micro-scaffolds of microscopic dimensions which enable seeded cells to obtain gases and nutrients through diffusion thus avoiding the need for vascularization. As a proof of concept, we show that in this model, Calu-3 cells can form a well-organized, continuous, polarized, one-layer epithelium lining the stromal derived alveolar cavities, and express a different pattern of tumor-related genes than when grown as standard monolayer cultures on plastic culture dishes. To our knowledge, this model, introduces for the first time a system where the function of carcinogenic cells can be tested in vitro in an environment that closely mimics the natural in vivo situation.

Entities:  

Keywords:  carcinoma; decellularized scaffolds; tumor micro-culture; tumor microenvironment; tumor model

Year:  2019        PMID: 31192122      PMCID: PMC6540606          DOI: 10.3389/fonc.2019.00410

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  39 in total

1.  Organ-specific scaffolds for in vitro expansion, differentiation, and organization of primary lung cells.

Authors:  Yulia Shamis; Eilat Hasson; Avigail Soroker; Elad Bassat; Yael Shimoni; Tamar Ziv; Ronit Vogt Sionov; Eduardo Mitrani
Journal:  Tissue Eng Part C Methods       Date:  2011-05-19       Impact factor: 3.056

2.  Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules.

Authors:  Dhruva K Mishra; Michael J Thrall; Brandi N Baird; Harald C Ott; Shanda H Blackmon; Jonathan M Kurie; Min P Kim
Journal:  Ann Thorac Surg       Date:  2012-03-02       Impact factor: 4.330

Review 3.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 4.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.

Authors:  Mina J Bissell; William C Hines
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

5.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 6.  Targeting the tumor microenvironment.

Authors:  Paraic A Kenny; Genee Y Lee; Mina J Bissell
Journal:  Front Biosci       Date:  2007-05-01

7.  Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.

Authors:  Christopher Jedeszko; Bernadette C Victor; Izabela Podgorski; Bonnie F Sloane
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

Review 8.  The tumor microenvironment is a dominant force in multidrug resistance.

Authors:  Ana Luísa Correia; Mina J Bissell
Journal:  Drug Resist Updat       Date:  2012-02-13       Impact factor: 18.500

9.  Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.

Authors:  Yun-Ge Zhao; Ai-Zhen Xiao; Hyun I Park; Robert G Newcomer; Mei Yan; Yan-Gao Man; Sue C Heffelfinger; Qing-Xiang Amy Sang
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

10.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

Authors:  B Mintz; K Illmensee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.